Gani Nuredini,Alec Saunders,Chakravarthi Rajkumar et al.
Gani Nuredini et al.
White coat hypertension (WCH) is characterised by an elevated clinic blood pressure (BP) with normal ambulatory or home BP. It is well recognised in clinical practice and occurs in approximately one-third of untreated patients with elevated...
Exercise therapy in routine management of peripheral arterial disease and intermittent claudication: a scoping review [0.03%]
外周动脉疾病和间歇性跛行常规管理中的运动疗法：系统综述
Ukachukwu O Abaraogu,Onyinyechukwu D Abaraogu,Philippa M Dall et al.
Ukachukwu O Abaraogu et al.
Background: Little is known about the extent to which routine care management of peripheral arterial disease (PAD) and intermittent claudication (IC) align with best practice recommendations on exercise therapy. We conduc...
Antithrombotic and hemostatic stewardship: evaluation of clinical outcomes and adverse events of recombinant factor VIIa (Novoseven®) utilization at a large academic medical center [0.03%]
关于重组活化因子VII在大型医学中心使用的效果和不良事件的药物管理研究
Kassandra Marsh,David Green,Veronica Raco et al.
Kassandra Marsh et al.
Background: Recombinant factor VIIa (rFVIIa) (Novoseven®) is utilized for the reversal of anticoagulation-associated bleeding and refractory bleeding in cardiac surgery. In August 2015, rFVIIa was transferred from the bl...
Endovascular approach for acute limb ischemia without thrombolytic therapy [0.03%]
未使用溶栓疗法的急性肢体缺血的血管内治疗
Keisuke Fukuda,Yoshiaki Yokoi
Keisuke Fukuda
Background: Endovascular therapy for acute lower limb ischemia (ALLI) has developed and demonstrated safety and efficacy. The purpose of this study was to assess clinical outcomes in patients treated for ALLI with convent...
Inter-observer variation of Syntax score among cardiac surgeons, clinical and interventional cardiologists [0.03%]
心脏外科医生、临床和介入性心脏病医生之间Syntax评分的观察者间变异度研究
Gustavo Neves de Araujo,Tiago Luiz Luz Leiria,Mariana Vargas Furtado et al.
Gustavo Neves de Araujo et al.
Background: Despite the complexity of SYNTAX score (SS), guidelines recommend this tool to help choosing between coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) in patients with left ma...
Multicap to improve adherence after acute coronary syndromes: results of a randomized controlled clinical trial [0.03%]
多重用药依从性改善急性冠脉综合征患者治疗依从性的随机对照临床试验结果
Javier Mariani,Andrés Rosende,Maximiliano De Abreu et al.
Javier Mariani et al.
Background: Adherence to treatment after a myocardial infarction (MI) is poor, even in the early postinfarction period. Combining evidence-based drugs into a multicap could improve adherence in this population. No previou...
Randomized Controlled Trial
Therapeutic advances in cardiovascular disease. 2020 Jan-Dec:14:1753944720912071. DOI:10.1177/1753944720912071 2020
Endpoint selection for noninferiority percutaneous coronary intervention trials: a methodological description [0.03%]
非劣性经皮冠状动脉介入治疗试验的结局选择：方法学描述
Matthias Waliszewski,Mark Rosenberg,Harald Rittger et al.
Matthias Waliszewski et al.
Background: The objective of this review is to provide a practical update on endpoint selection for noninferiority (NI) studies in percutaneous coronary intervention studies. ...
Acute right heart failure: future perspective with the PERKAT RV pulsatile right ventricular support device [0.03%]
急性右心衰竭：带有PERKAT RV脉动右心室辅助装置的未来展望
Markus W Ferrari,P Christian Schulze,Daniel Kretzschmar
Markus W Ferrari
Acute right heart failure is associated with impaired prognosis in cardiogenic shock. Since most pharmacological therapies are not evaluated for the failing right ventricle, or even contraindicated, there is a need for rapid minimal invasiv...
Importance of sodium-glucose cotransporter 2 inhibitor use in diabetic patients with acute heart failure [0.03%]
钠葡萄糖协同转运蛋白2抑制剂在急性心力衰竭合并糖尿病患者中的应用价值
Takahiro Kambara,Rei Shibata,Hiroyuki Osanai et al.
Takahiro Kambara et al.
Background: It is known that once heart failure occurs in older patients with diabetes, the overall prognosis is extremely poor. We investigated whether early initiation of SGLT2 inhibitor therapy after admission was bene...
Intravenous antiplatelet therapies (glycoprotein IIb/IIIa receptor inhibitors and cangrelor) in percutaneous coronary intervention: from pharmacology to indications for clinical use [0.03%]
经皮冠状动脉介入治疗中抗血小板药物（血小板糖蛋白IIb/IIIa受体抑制剂和坎格雷洛）从药理学至临床应用指征的演变
Davide Capodanno,Rocco P Milluzzo,Dominick J Angiolillo
Davide Capodanno
Oral antiplatelet drugs are crucially important for patients with acute coronary syndrome or stable coronary artery disease undergoing percutaneous coronary intervention (PCI). In recent decades, several clinical trials have focused on redu...